Scott R. Hamann

1.1k total citations
37 papers, 929 citations indexed

About

Scott R. Hamann is a scholar working on Physiology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Scott R. Hamann has authored 37 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Cellular and Molecular Neuroscience and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Scott R. Hamann's work include Pain Mechanisms and Treatments (10 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Epilepsy research and treatment (8 papers). Scott R. Hamann is often cited by papers focused on Pain Mechanisms and Treatments (10 papers), Cardiac electrophysiology and arrhythmias (9 papers) and Epilepsy research and treatment (8 papers). Scott R. Hamann collaborates with scholars based in United States, Taiwan and Germany. Scott R. Hamann's co-authors include R. G. McAllister, Robert A. Blouin, Patrick Bryant, Thomas S. Foster, David A. Graves, Daniel A. Todd, W R Martin, William R. Martin, Jewell W. Sloan and Paul A. Sloan and has published in prestigious journals such as Neuroscience, The American Journal of Cardiology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Scott R. Hamann

37 papers receiving 850 citations

Peers

Countries citing papers authored by Scott R. Hamann

Since Specialization

Citations

This map shows the geographic impact of Scott R. Hamann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott R. Hamann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott R. Hamann more than expected).

Fields of papers citing papers by Scott R. Hamann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott R. Hamann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott R. Hamann. The network helps show where Scott R. Hamann may publish in the future.

Co-authorship network of co-authors of Scott R. Hamann

This figure shows the co-authorship network connecting the top 25 collaborators of Scott R. Hamann. A scholar is included among the top collaborators of Scott R. Hamann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott R. Hamann. Scott R. Hamann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia: A case report 2018 ·Journal of Opioid Management ·Scott R. Hamann, Paul A. Sloan, William Witt	4
2	Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord 2014 ·Neuroscience ·Chih‐Lung Lin, Paula M. Heron, Scott R. Hamann, George M. Smith	22
3	Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: A randomized, double-blind, prospective pilot study 2007 ·Journal of Opioid Management ·Scott R. Hamann, Paul A. Sloan	14
4	Ultra-low-dose opioid antagonists to enhance opioid analgesia 2006 ·Journal of Opioid Management ·Paul A. Sloan, Scott R. Hamann	15
5	Interactions of ?Ultra-Low? Doses of Naltrexone and Morphine in Mature and Young Male and Female Rats 2004 ·PubMed ·Scott R. Hamann, (unknown), Jewell W. Sloan, Elzbieta P. Wala	15
6	Hepatic gene expression patterns in thyroid hormone-treated hypothyroid rats 2003 ·Journal of Molecular Endocrinology ·Joachim M. Weitzel, Scott R. Hamann, (unknown), Michelle Lacey, (unknown), (unknown), (unknown), (unknown), Angelika Harneit, P. M. Lizardi, (unknown)	55
7	Advances in cancer pain management 2001 ·Current Pain and Headache Reports ·(unknown), Jewell W. Sloan, Scott R. Hamann	15
8	Advances in cancer pain management 2000 ·Current Oncology Reports ·(unknown), Jewell W. Sloan, Scott R. Hamann	15
9	Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone, and (−)-lobeline in the rat brainstem 1994 ·Pharmacology Biochemistry and Behavior ·Scott R. Hamann, William R. Martin	22
10	Opioid and nicotinic analgesic and hyperalgesic loci in the rat brain stem. 1992 ·Journal of Pharmacology and Experimental Therapeutics ·Scott R. Hamann, W R Martin	33
11	Analgesic actions of dynorphin A(1–13) antiserum in the rat brain stem 1992 ·Brain Research Bulletin ·Scott R. Hamann, William R. Martin	10
12	Analgesic actions of local anesthetics and cobalt chloride in the rat brain stem 1992 ·Pharmacology Biochemistry and Behavior ·Scott R. Hamann, J. Holtman, William R. Martin	2
13	Thermally evoked tail avoidance reflex: Input-output relationships and their modulation 1992 ·Brain Research Bulletin ·Scott R. Hamann, William R. Martin	9
14	Conscious State Comparisons of the Effects of the Inhalation Anesthetics and Diltiazem, Nifedipine, or Verapamil on Specialized Atrioventricular Conduction Times in Spontaneously Beating Dog Hearts 1988 ·Anesthesiology ·John L. Atlee, Scott R. Hamann, Susan Brownlee, (unknown)	18
15	Hemodynamic and Pharmacokinetic Aspects of the Interactions between Verapamil and Pindolol 1987 ·Pharmacology ·Scott R. Hamann, (unknown), R. G. McAllister	1
16	Nifedipine-Propranolol Interaction 1987 ·Journal of Cardiovascular Pharmacology ·Scott R. Hamann, (unknown), R. G. McAllister	6
17	Kinetics and dynamics of calcium entry antagonists in systemic hypertension 1986 ·The American Journal of Cardiology ·R. G. McAllister, (unknown), Scott R. Hamann	16
18	Effects of Phenobarbital and SKF-525A on in vitro Hepatic Metabolism of Verapamil and Nifedipine 1985 ·Pharmacology ·Scott R. Hamann, (unknown), (unknown), Kim L. R. Brouwer, Robert A. Blouin, (unknown), Mary Vore, R. G. McAllister	12
19	Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine. 1984 ·Journal of Pharmacology and Experimental Therapeutics ·Scott R. Hamann, Robert A. Blouin, (unknown), (unknown), (unknown), R. G. McAllister	16
20	Nifedipine Kinetics and Bioavailability After Single Intravenous and Oral Doses in Normal Subjects 1983 ·The Journal of Clinical Pharmacology ·Thomas S. Foster, Scott R. Hamann, (unknown), Patrick Bryant, David A. Graves, R. G. McAllister	176

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact